Orchard Therapeutics (ORTX) PT Lowered to $4 at Stifel
Tweet
Share
E-mailGet Alerts ORTX Hot Sheet
Price: $16.70 --0%
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $4.00 (from $5.00) while maintaining a Buy rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Dell (DELL) PT Raised to $500; TD Cowen: 'Phenomenal Results & Guidance'
- GitLab Inc (GTLB) PT Raised to $55 at DA Davidson, Neutral Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
